Androgen deprivation therapy is a standard of care for metastatic prostate cancer, however, eventually, all men relapse. A paradoxical approach utilizing high doses of testosterone in castration-resistant prostate cancer patients demonstrated clinical responses. Here we report on four heavily pretreated CRPC patients successfully treated with supra-physiological doses of testosterone.